{"transactions":[{"id":940098,"issuer":{"id":7525,"kind":"organization","name":"Lantern Pharma Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-13T21:05:12.000Z","date":"2026-01-09","kind":"grant","planned":false,"acquired":true,"shares":21152,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 12-month period commencing February 9, 2026."}],"balance_after":21152,"derivative":{"exercise_price":3.49,"expiration_date":"2036-01-08","underlying":"Common Stock","underlying_shares":21152},"source":{"system":"sec-edgar","filing":"0001493152-26-002025","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1763950/000149315226002025/ownership.xml","form_type":"4"}},{"id":940097,"issuer":{"id":7525,"kind":"organization","name":"Lantern Pharma Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-13T21:05:12.000Z","date":"2026-01-09","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 24-month period commencing February 9, 2026."}],"balance_after":25000,"derivative":{"exercise_price":3.49,"expiration_date":"2036-01-08","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-26-002025","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1763950/000149315226002025/ownership.xml","form_type":"4"}},{"id":1001951,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-11-12T14:19:04.000Z","date":"2025-10-28","kind":"purchase","planned":false,"acquired":true,"shares":97561,"price":2.05,"value":200000.05,"ownership":{"direct":true},"balance_after":1212020,"source":{"system":"sec-edgar","filing":"0001104659-25-109906","document":"tm2527472-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925109906/tm2527472-3_4seq1.xml","form_type":"4"}},{"id":1121247,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-06-05T10:00:15.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":46000,"price":3.37,"value":155020.0,"ownership":{"direct":true},"balance_after":1114459,"source":{"system":"sec-edgar","filing":"0001104659-25-056578","document":"tm2517204-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925056578/tm2517204-1_4seq1.xml","form_type":"4"}},{"id":1452648,"issuer":{"id":7525,"kind":"organization","name":"Lantern Pharma Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-17T20:30:17.000Z","date":"2024-07-15","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options will vest and first become exercisable in equal monthly increments over a 36-month period commencing August 15, 2024."}],"balance_after":5000,"derivative":{"exercise_price":4.35,"expiration_date":"2034-07-15","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001493152-24-028185","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1763950/000149315224028185/ownership.xml","form_type":"4"}},{"id":1459845,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-07-03T21:16:55.000Z","date":"2023-11-17","kind":"grant","planned":false,"acquired":true,"shares":108800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"The stock option was granted in lieu of cash payment for 2023 fiscal year bonus. 100% of the stock option grant listed was also contingent upon the aforementioned amendment to the 2019 Equity Incentive Plan to increase the number of issuable shares from 2,000,000 to 3,000,000. It would have been forfeited if the amendment had not been approved."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option shall vest immediately."}],"balance_after":108800,"derivative":{"exercise_price":6.07,"expiration_date":"2033-11-17","underlying":"Common Stock","underlying_shares":108800},"source":{"system":"sec-edgar","filing":"0001104659-24-077834","document":"tm2417696-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465924077834/tm2417696-3_4seq1.xml","form_type":"4"}},{"id":1459844,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-07-03T21:16:55.000Z","date":"2023-11-17","kind":"grant","planned":false,"acquired":true,"shares":252000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"On June 12, 2024, stockholders of Annovis Bio, Inc. approved an amendment to the 2019 Equity Incentive Plan to increase the number of shares issuable thereunder from 2,000,000 to 3,000,000. 50% of the stock option grant listed was contingent upon the approval of such amendment and would have been forfeited if the amendment had not been approved."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Stock option will vest in eight consecutive quarterly installments of 31,500 shares each on the 17th day of February, May, August and November of each year, continuing through November 17, 2025."}],"balance_after":252000,"derivative":{"exercise_price":6.07,"expiration_date":"2033-11-17","underlying":"Common Stock","underlying_shares":252000},"source":{"system":"sec-edgar","filing":"0001104659-24-077834","document":"tm2417696-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465924077834/tm2417696-3_4seq1.xml","form_type":"4"}},{"id":1459843,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-03T21:16:55.000Z","date":"2024-03-31","kind":"gift","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents charitable gifts donated by the reporting person. No proceeds were received by the reporting person."}],"balance_after":1068459,"source":{"system":"sec-edgar","filing":"0001104659-24-077834","document":"tm2417696-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465924077834/tm2417696-3_4seq1.xml","form_type":"4"}},{"id":1459842,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-03T21:16:55.000Z","date":"2024-03-31","kind":"gift","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents charitable gifts donated by the reporting person. No proceeds were received by the reporting person."}],"balance_after":1078459,"source":{"system":"sec-edgar","filing":"0001104659-24-077834","document":"tm2417696-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465924077834/tm2417696-3_4seq1.xml","form_type":"4"}},{"id":1459841,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-03T21:16:55.000Z","date":"2024-03-28","kind":"gift","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents charitable gifts donated by the reporting person. No proceeds were received by the reporting person."}],"balance_after":1088459,"source":{"system":"sec-edgar","filing":"0001104659-24-077834","document":"tm2417696-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465924077834/tm2417696-3_4seq1.xml","form_type":"4"}},{"id":1731158,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-11-22T21:23:15.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":40970,"price":6.1,"value":249917.0,"ownership":{"direct":true},"balance_after":1098459,"source":{"system":"sec-edgar","filing":"0001104659-23-120762","document":"tm2331305-11_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923120762/tm2331305-11_4aseq1.xml","form_type":"4/A","original_submission_date":"2023-11-21"}},{"id":1732546,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-11-21T19:30:35.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":41186,"price":6.07,"value":249999.02,"ownership":{"direct":true},"balance_after":1098675,"source":{"system":"sec-edgar","filing":"0001104659-23-120302","document":"tm2331305-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923120302/tm2331305-3_4seq1.xml","form_type":"4"}},{"id":1913305,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-26T20:34:01.000Z","date":"2023-04-24","kind":"gift","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1057489,"source":{"system":"sec-edgar","filing":"0001104659-23-050393","document":"tm2313853-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923050393/tm2313853-1_4seq1.xml","form_type":"4"}},{"id":1921738,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-12T01:03:33.000Z","date":"2023-04-07","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":12.61,"value":252200.0,"ownership":{"direct":true},"balance_after":1060489,"source":{"system":"sec-edgar","filing":"0001104659-23-044202","document":"tm2312464-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923044202/tm2312464-1_4seq1.xml","form_type":"4"}},{"id":2026470,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-08T22:11:34.000Z","date":"2023-02-06","kind":"exercise","acquired":false,"shares":52755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the shares underlying the option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.14,"expiration_date":"2027-04-01","underlying":"Common Stock","underlying_shares":52755},"source":{"system":"sec-edgar","filing":"0001104659-23-014610","document":"tm231947-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923014610/tm231947-2_4seq1.xml","form_type":"4"}},{"id":2026469,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-08T22:11:34.000Z","date":"2023-02-06","kind":"exercise","acquired":true,"shares":52755,"price":0.14,"value":7385.7,"ownership":{"direct":true},"balance_after":1040489,"source":{"system":"sec-edgar","filing":"0001104659-23-014610","document":"tm231947-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923014610/tm231947-2_4seq1.xml","form_type":"4"}},{"id":2049602,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-20T22:43:08.000Z","date":"2023-01-18","kind":"grant","acquired":true,"shares":21312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in eight consecutive quarterly installments of 2,664 shares each on the 18th day of April, July, October and January of each year, commencing April 18, 2023, and continuing through January 18, 2025."}],"balance_after":21312,"derivative":{"exercise_price":13.17,"expiration_date":"2033-01-18","underlying":"Common Stock","underlying_shares":21312},"source":{"system":"sec-edgar","filing":"0001104659-23-005481","document":"tm234043-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923005481/tm234043-6_4seq1.xml","form_type":"4"}},{"id":2133018,"issuer":{"id":7525,"kind":"organization","name":"Lantern Pharma Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-24T21:57:08.000Z","date":"2022-10-20","kind":"grant","acquired":true,"shares":3200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option is granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. 356 shares of the Option vested on the day of grant, with the remaining Option shares to vest in equal monthly installments commencing November 8, 2022 with last vesting on June 8, 2025."}],"balance_after":3200,"derivative":{"exercise_price":4.79,"expiration_date":"2032-10-19","underlying":"Common Stock","underlying_shares":3200},"source":{"system":"sec-edgar","filing":"0001493152-22-029456","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1763950/000149315222029456/ownership.xml","form_type":"4"}},{"id":2433720,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-19T02:08:43.000Z","date":"2022-01-14","kind":"exercise","acquired":false,"shares":32959,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the shares underlying the option are fully vested and exercisable."}],"balance_after":52755,"derivative":{"exercise_price":0.14,"expiration_date":"2027-04-01","underlying":"Common Stock","underlying_shares":32959},"source":{"system":"sec-edgar","filing":"0001104659-22-005059","document":"tm221949-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922005059/tm221949-7_4seq1.xml","form_type":"4"}},{"id":2433719,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-19T02:08:43.000Z","date":"2022-01-14","kind":"exercise","acquired":true,"shares":32959,"price":0.14,"value":4614.26,"ownership":{"direct":true},"balance_after":987734,"source":{"system":"sec-edgar","filing":"0001104659-22-005059","document":"tm221949-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922005059/tm221949-7_4seq1.xml","form_type":"4"}},{"id":2433707,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-19T02:07:46.000Z","date":"2021-12-20","kind":"gift","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Charitable gift."}],"balance_after":954775,"source":{"system":"sec-edgar","filing":"0001104659-22-005057","document":"tm221949-8_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922005057/tm221949-8_5seq1.xml","form_type":"5"}},{"id":2433706,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-19T02:07:46.000Z","date":"2021-07-01","kind":"gift","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Charitable gift."}],"balance_after":974775,"source":{"system":"sec-edgar","filing":"0001104659-22-005057","document":"tm221949-8_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922005057/tm221949-8_5seq1.xml","form_type":"5"}},{"id":2433705,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-19T02:07:46.000Z","date":"2021-07-01","kind":"gift","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Charitable gift."}],"balance_after":975775,"source":{"system":"sec-edgar","filing":"0001104659-22-005057","document":"tm221949-8_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922005057/tm221949-8_5seq1.xml","form_type":"5"}},{"id":2433704,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-19T02:07:46.000Z","date":"2020-07-15","kind":"gift","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Charitable gift that was not previously reported in a Form 5 for the fiscal year ended December 31, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"Charitable gift."}],"balance_after":976775,"source":{"system":"sec-edgar","filing":"0001104659-22-005057","document":"tm221949-8_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922005057/tm221949-8_5seq1.xml","form_type":"5"}},{"id":2433703,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-19T02:07:46.000Z","date":"2020-04-27","kind":"gift","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Charitable gift that was not previously reported in a Form 5 for the fiscal year ended December 31, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"Charitable gift."}],"balance_after":986775,"source":{"system":"sec-edgar","filing":"0001104659-22-005057","document":"tm221949-8_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922005057/tm221949-8_5seq1.xml","form_type":"5"}},{"id":2443822,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-06T00:42:22.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":19894,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest and become exercisable in two equal installments of 9,947 shares on March 31, 2022 and March 31, 2023."}],"balance_after":19894,"derivative":{"exercise_price":19.78,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":19894},"source":{"system":"sec-edgar","filing":"0001104659-22-001640","document":"tm221949-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922001640/tm221949-3_4seq1.xml","form_type":"4"}},{"id":2443821,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-06T00:42:22.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":83400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in eight consecutive quarterly installments of 10,425 shares each on the 3rd day of April, July, October and January of each year, commencing April 3, 2022, and continuing through January 3, 2024."}],"balance_after":83400,"derivative":{"exercise_price":19.78,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":83400},"source":{"system":"sec-edgar","filing":"0001104659-22-001640","document":"tm221949-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922001640/tm221949-3_4seq1.xml","form_type":"4"}},{"id":2480596,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-08T22:00:47.000Z","date":"2021-12-06","kind":"grant","acquired":true,"shares":145305,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest in two installments: (i) the first installment of 72,653 shares on March 31, 2022 and (ii) a second and final installment of 72,652 shares on March 31, 2023, provided that the reporting person continues to be employed by the issuer on the applicable vesting date."}],"balance_after":145305,"derivative":{"exercise_price":20.97,"expiration_date":"2031-12-06","underlying":"Common Stock","underlying_shares":145305},"source":{"system":"sec-edgar","filing":"0001104659-21-147673","document":"tm2134914-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465921147673/tm2134914-1_4seq1.xml","form_type":"4"}},{"id":2480595,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-08T22:00:47.000Z","date":"2021-12-06","kind":"grant","acquired":true,"shares":112995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option is 100% vested."}],"balance_after":112995,"derivative":{"exercise_price":20.97,"exercise_date":"2021-12-06","expiration_date":"2031-12-06","underlying":"Common Stock","underlying_shares":112995},"source":{"system":"sec-edgar","filing":"0001104659-21-147673","document":"tm2134914-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465921147673/tm2134914-1_4seq1.xml","form_type":"4"}},{"id":2543359,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2021-10-13T20:00:52.000Z","date":"2021-10-11","kind":"purchase","acquired":true,"shares":18000,"price":27.61,"value":496980.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $27.58 to $27.64, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price."}],"balance_after":976775,"source":{"system":"sec-edgar","filing":"0001415889-21-004862","document":"form4-10132021_011036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000141588921004862/form4-10132021_011036.xml","form_type":"4"}},{"id":2637010,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-07-09T22:27:12.000Z","date":"2021-07-07","kind":"grant","acquired":true,"shares":41700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in eight substantially equal quarterly installments beginning October 7, 2021, provided that the reporting person continues to be employed by the issuer on the applicable vesting date."}],"balance_after":41700,"derivative":{"exercise_price":102.85,"expiration_date":"2031-07-07","underlying":"Common Stock","underlying_shares":41700},"source":{"system":"sec-edgar","filing":"0001104659-21-090743","document":"tm2121908-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465921090743/tm2121908-3_4seq1.xml","form_type":"4"}},{"id":3177916,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-14T00:06:00.000Z","date":"2020-04-09","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":300000,"derivative":{"exercise_price":3.13,"exercise_date":"2020-04-09","expiration_date":"2030-04-09","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001104659-20-046066","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465920046066/a4.xml","form_type":"4"}},{"id":3288597,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Series A Preferred Stock","published_at":"2020-02-05T11:03:41.000Z","date":"2020-01-31","kind":"exercise","acquired":false,"shares":1068054,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into common stock of Annovis upon the closing of the IPO at a conversion ratio of one for 0.7143."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into common stock of Annovis upon the closing of the IPO at a conversion ratio of one for 0.7143."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into common stock of Annovis upon the closing of the IPO at a conversion ratio of one for 0.7143."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":762896},"source":{"system":"sec-edgar","filing":"0001104659-20-010939","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465920010939/a4.xml","form_type":"4"}},{"id":3288596,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Series A-1 Preferred Stock","published_at":"2020-02-05T11:03:41.000Z","date":"2020-01-31","kind":"exercise","acquired":false,"shares":11111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series A-1 Preferred Stock automatically converted into common stock of Annovis upon the closing of the IPO at a conversion ratio of one for 0.7143."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series A-1 Preferred Stock automatically converted into common stock of Annovis upon the closing of the IPO at a conversion ratio of one for 0.7143."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series A-1 Preferred Stock automatically converted into common stock of Annovis upon the closing of the IPO at a conversion ratio of one for 0.7143."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7937},"source":{"system":"sec-edgar","filing":"0001104659-20-010939","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465920010939/a4.xml","form_type":"4"}},{"id":3288595,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-02-05T11:03:41.000Z","date":"2020-01-31","kind":"exercise","acquired":true,"shares":762896,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into common stock of Annovis upon the closing of the IPO at a conversion ratio of one for 0.7143."}],"balance_after":978775,"source":{"system":"sec-edgar","filing":"0001104659-20-010939","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465920010939/a4.xml","form_type":"4"}},{"id":3288594,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-02-05T11:03:41.000Z","date":"2020-01-31","kind":"exercise","acquired":true,"shares":7937,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series A-1 Preferred Stock automatically converted into common stock of Annovis upon the closing of the IPO at a conversion ratio of one for 0.7143."}],"balance_after":215879,"source":{"system":"sec-edgar","filing":"0001104659-20-010939","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465920010939/a4.xml","form_type":"4"}},{"id":3288593,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":69441,"kind":"person","name":"Maccecchini Maria-Luisa","position":1,"cik":"0001315018","reported_name":"Maccecchini Maria-Luisa","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-02-05T11:03:41.000Z","date":"2020-01-31","kind":"purchase","acquired":true,"shares":1600,"price":6,"value":9600.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person acquired these shares in the initial public offering (\"IPO\") of Annovis Bio, Inc. (\"Annovis\")."}],"balance_after":207942,"source":{"system":"sec-edgar","filing":"0001104659-20-010939","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465920010939/a4.xml","form_type":"4"}}]}